Table 1.
Vaccine | Manufacturer | Vaccine type | Storage temperature | Efficacy |
---|---|---|---|---|
BNT162b2 | Pfizer (US)- BioNTech (Germany) | Messenger RNA | −70 °C | 95% |
mRNA1273 | ModernaTX Inc. (US) | Messenger RNA | 2–8 °C | 95% |
AZD 1222 | University of Oxford-AstraZeneca (UK) | Non-replicating Viral vector | 2–8 °C | 70% |
Sputnik-V | Gamaleya Research Institute (Russia) | Non-replicating Viral vector | −18 °C | 92% |
CoronaVac | Sinovac Biotech (China) | Inactivated virus | 2–8 °C | 50% |
Johnson & Johnson* | Janssen Pharmaceutical Companies (Belgium/US) | Non-replicating Viral vector | 2–8 °C | 66% |
requires single dosing.
Sources: Bloomberg COVID-19 vaccine tracker, https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/.
U.S. Centers for Disease Control and Prevention, https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines.html.
Milken Institute COVID-19 vaccine tracker, https://airtable.com/shrSAi6t5WFwqo3GM/tblEzPQS5fnc0FHYR/viwDBH7b6FjmIBX5x?blocks=bipZFzhJ7wHPv7x9z.